NEWS

Medlab Clinical & QUT Clinical Trial with NRGBiotic for Depression Begins

Medlab Clinical and QUT are conducting a clinical trial to assess NRGBioticTM in the management of depression. The clinical trial follows on from two pilot studies which produced significant results of positive clinical benefits to patients administered magnesium orotate and NRGBioticTM respectively.

www.qut.edu.au/news

NRGBioticTM:

https://www.brisbanetimes.com.au/lifestyle/health-and-wellness/could-probiotics-be-the-answer-to-depression-20180724-p4zte9.html

https://www.smh.com.au/lifestyle/health-and-wellness/could-probiotics-be-the-answer-to-depression-20180724-p4zte9.html


Executive Series 21 Jun 18: Medlab Clinical Ltd (MDC) CEO & Managing Director, Sean Hall

Medlab Clinical Ltd (MDC) CEO & Managing Director, Sean Hall speaks with Tom Piotrowski about the company’s nutraceuticals sales and its cannabis clinical trial that’s currently underway.


NEW PRODUCTS

StemGuard

StemGuard

Medlab's long-awaited StemGuard has arrived, and it's brimming with high dose Coenzyme Q10, Green Tea extract, Vitamin D3, wild Blueberry extract, Broccoli Sprout concentrate, Organic Spirulina, L-carnitine, and Cocoa, all packed in a dark chocolate peppermint formula.

This scientifically formulated combination of ingredients in StemGuard aids liver detoxification, cellular energy production, cardiovascular health, hormone metabolism, and supports immunity.

Whether you’re feeling fatigued or just looking for that extra boost in your routine, add this to your morning beverage and go!

More Information
MEDLAB EFFICACY MAGAZINE

Medlab's New EfficacyTM Magazine

A true integrative approach to medicine and health

Issue 7: January 2018 - March 2018

The Human Microbiome


Medlab’s quarterly magazine designed to educate and update Practitioners with Medlab research and industry advancements with a variety of contributing authors. Register or log in to view today.